Furthermore, septic mice models demonstrated that luteolin pre-treatment ameliorated sepsis-induced ALI through the inhibition of oxidative stress, NF-κB, ICAM-1, and iNOS [151]. The gene discussed is NOS2; the disease is Sepsis.